Stem Cell
Stem Cell
Stem Cell
Stem Cell: One daughter cell retains the properties of the original
stem cell, maintaining the stem cell pool.
Induced pluripotent stem (iPS) cells, are a type of pluripotent stem cell derived from adult somatic cells. They have
been reprogrammed through inducing genes and factors to be pluripotent.
Sox2 is essential for maintaining self-renewal, or pluripotency, of undifferentiated embryonic stem cells
KLF4 is involved in the regulation of proliferation, differentiation, apoptosis and somatic cell reprogramming
Generation of iPSCs
Somatic Cells: Start with differentiated adult cells, such as skin fibroblasts.
Reprogramming Factors: Introduce a set of specific genes (usually four key transcription factors:
Oct4, Sox2, Klf4, and c-Myc, known as the Yamanaka factors) into these cells.
Gene Introduction Methods:
•Viral Vectors: The most common method, using retroviruses or lentiviruses to insert the
genes into the cell’s DNA.
•Non-Viral Methods: Include plasmid transfection, mRNA, or small molecules to avoid
potential risks associated with viral integration.
Reprogramming Process: Over a few weeks, the introduced genes reprogram the somatic cells to
revert to a pluripotent state
https://www.youtube.com/watch?v=2yolY8anIQo
Applications of iPSCs
Regenerative Medicine: Potential for repairing damaged tissues or organs, such as heart cells for heart disease or
neurons for neurodegenerative diseases.
Disease Modeling: iPSCs can be derived from patients with specific genetic disorders to create models of diseases like
Parkinson’s, ALS, or diabetes. This allows for the study of disease progression and the testing of new drugs.
Drug Screening and Development: iPSCs provide a platform for high-throughput screening of drug candidates in a
personalized manner.
Toxicology Testing: Testing the effects of drugs or chemicals on various cell types derived from iPSCs to assess safety
Disadvantages
Genomic Stability: Concerns about potential mutations during reprogramming or prolonged culture.
Efficiency of Reprogramming: The reprogramming process is not 100% efficient, and not all cells become fully pluripotent.
Safety Issues: The use of viral vectors, particularly with oncogenes like c-Myc, raises the risk of tumorigenesis, although newer,
non-integrating methods are being developed.